Comparative clinical study of Amritadi tablet and Arbudhar tablet in the management of Oral Cancer.
Phase 2
- Conditions
- Health Condition 1: C069- Malignant neoplasm of mouth, unspecifiedHealth Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 3: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 4: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 5: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2022/06/043204
- Lead Sponsor
- Government Akhandanand Ayurved College Ahmedabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with sign and symptoms of squamous cell carcinoma like
1.Mouth ulceration
2.Sore tounge
3.Jaw swelling
4.Pain in the oral cavity
5.Trismus
6.patient diagnosed as squamous cell carcinoma after histopathological report
7.TNM CRITERIA T1N0M0 T2N0M0 T3N0M0
8.Post surgical case
Exclusion Criteria
1.Metastatis
2.Patients suffering from severe systemic disorders and diseases like HIV,Hbsag,STD,TB
3.Uncontrolled DM and HTN
4.Cardiac or Renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method